Chronic respiratory diseases in developing countries: The burden and strategies for prevention and management

Bulletin of the World Health Organization

Volumn 79, Issue 10, 2001, Pages 971-979

  Aït Khaled, Nadia ^a   Enarson, Donald ^a   Bousquet, Jean ^b,c  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c INSERM   (France)

Author keywords

Asthma economics prevention and control epidemiology; Cost of illness; Developing countries (source: MeSH); Essential drugs; Lung diseases, Obstructive economics prevention and control epidemiology; Smoking cessation

Indexed keywords

CORTICOSTEROID; ESSENTIAL DRUG;

DISEASE CONTROL; DRUG PRESCRIBING; HEALTH CARE; PUBLIC HEALTH; RESPIRATORY DISEASE; TOBACCO;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; DEVELOPING COUNTRY; DRUG MEGADOSE; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; PROPHYLAXIS; REVIEW; SMOKING;

ANTI-ASTHMATIC AGENTS; ASTHMA; COST OF ILLNESS; DEVELOPING COUNTRIES; DISABLED PERSONS; DRUGS, ESSENTIAL; HEALTH CARE RATIONING; HEALTH POLICY; HEALTH PRIORITIES; HUMANS; POVERTY; PUBLIC HEALTH PRACTICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING CESSATION;

EID: 0034762926     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Causes of death in industrial and developing countries: Estimates for 1985-1990
2. Urban and social origins of childhood bronchitis in England and Wales
3. Socioeconomic status, lung function and admission to hospital for COPD: Results from the Copenhagen City Heart Study
4. After health sector reform, whither lung health
5. Evidence-based health policy-lessons from the global burden of disease study
6. Analysis of basic data of the study on prevention and treatment of COPD
7. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function
8. Decline of FEV1 by age and smoking status: Facts, figures and fallacies
9. The Lung Health Study. Disappointment and triumph. Editorial
10. Prévalence de la bronchite chronique en milieu industriel au Maroc
11. Respiratory symptoms and occupational bronchitis in chromite ore miners, Sudan
12. A respiratory epidemiological survey of grain mill workers in Cape Town, South Africa
13. Domestic smoke pollution and chronic bronchitis in a rural community of Hill Region of Nepal
14. Exposure to biomass smoke and chronic airway disease in Mexican Women
15. Respiratory symptoms in Indian women using domestic cooking fuels
16. The relationship between respiratory illness in childhood and chronic airflow obstruction in adulthood
17. Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: A population based study
18. Pulmonary tuberculosis: Clinical features
19. Le tabac en Afrique
20. Tobacco and the developing world
21. Women and smoking: A global issue
22. Validity and repeatability of the IUATLD (1984) bronchial symptoms questionnaire: An international comparison
23. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medications in the European Community Respiratory Health Survey (ECRHS)
24. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjonctivitis, and atopic eczema: ISAAC
25. L'asthme - Problème mondial de santé publique
26. Asthma - United States, 1980-1990
27. Relationship between mite densities and the prevalence of asthma, comparatives studies in two populations in the Eastern Papua New Guinea
28. The Global Burden of Disease Study: A useful projection of future global health?
29. The critique of DALYs: A counter-reply
30. Epidemiology and management of stable chronic obstructive pulmonary disease in Africa
31. Chronic obstructive pulmonary disease
32. Increase in deaths from asthma
33. Asthma mortality in New Zealand: A two-year national study
34. Age specific trends in asthma mortality in England and Wales, 1983-95: Results of an observational study
35. Low-dose inhaled corticosteroids and the prevention of deaths from asthma
36. Increase in hospital admission for childhood asthma: Trends in referral severity, and readmissions from 1975 to 1985 in a health region of the United Kingdom
37. Major reduction in asthma morbidity and continued reduction in mortality in New Zealand: What lessons have been learned?
38. Social deprivation and asthma
39. Variations in hospitalization rates for asthma among black and minorities ethic communities
40. Inadequate literacy is a barrier to asthma knowledge and self care
41. In what way may race, ethnicity or culture influence asthma outcomes?
42. Asthma among inner city children
43. Medications used by children with asthma living in the inner city
44. Reported difficulties in access to quality care for children with asthma in the inner city
45. The health economics of asthma and rhinitis. I. Assessing the economic impact
46. Health economics of asthma and rhinitis. II. Assessing the value of interventions
47. Current and future medical cost of asthma and chronic obstructive pulmonary disease in the Netherlands
48. An economic evaluation of asthma in the United States
49. The economic costs of asthma: A review and conceptual model
50. Allergic rhinitis in Rochester, Minnesota residents with asthma: Frequency and impact on health care charges
51. Advantages of high-dose inhaled budesonide
52. Cost effectiveness of inhaled corticosteroids plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma
53. National asthma education and prevention program. Working group report on the cost-effectiveness of asthma care
54. Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country
55. Standards for the diagnosis care of patients with chronic obstructive pulmonary disease (COPD)
56. BTS guidelines for the management of chronic obstructive pulmonary disease
57. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD)
58. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). European respiratory society consensus statement
59. Guidelines for the management of chronic obstructive pulmonary disease
60. Guidelines in the management of chronic obstructive pulmonary disease. A consensus statement
61. The message from the 1998 world asthma meeting
62. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries
63. Asthma in adults: Management and economic barriers
64. Recommended initial list of 39 international non-proprietary names for pharmaceutical substances